Medical Weight Loss Therapy
Practitioner-supervised metabolic support.
Overview
Understanding the treatment
Medical weight loss therapy is a practitioner-supervised program that may include medications working through metabolic and appetite-regulating pathways. It is intended to complement nutrition, activity, and lifestyle changes — not replace them.
Commonly discussed medications include semaglutide, tirzepatide, and the investigational compound retatrutide. These act on gut-hormone pathways: GLP-1 (glucagon-like peptide-1) helps regulate appetite and blood sugar; GIP (glucose-dependent insulinotropic polypeptide) also influences metabolism; and glucagon pathways affect energy use. Tirzepatide targets both GLP-1 and GIP, while retatrutide is studied for activity across GLP-1, GIP, and glucagon receptors.
Eligibility, medication selection, and dosing are determined by a licensed practitioner after evaluation. Programs include monitoring and ongoing support.
How It Works
A clear, step-by-step process
Medical evaluation
A licensed practitioner reviews your health history, goals, and any relevant lab work.
Mechanism education
We explain how GLP-1, GIP, and glucagon pathways influence appetite and metabolism.
Individualized plan
If appropriate, a medication and dose are selected alongside nutrition and lifestyle guidance.
Supervised titration
Dosing is adjusted gradually under supervision to balance benefit and tolerability.
Ongoing monitoring
Progress and side effects are reviewed regularly, and the plan is adapted.
Benefits
Clinically framed potential benefits when treatment is appropriate.
- Practitioner-supervised, individualized metabolic support
- Education on how GLP-1, GIP, and glucagon mechanisms work
- Integrates medication (when appropriate) with nutrition and lifestyle
- Structured monitoring and ongoing adjustment
Risks & Considerations
Honest disclosure matters. Discuss all risks with your provider.
- Common side effects include nausea, vomiting, diarrhea, constipation, and reduced appetite.
- More serious but less common risks can include pancreatitis, gallbladder problems, and dehydration.
- These medications are not appropriate for everyone and require medical screening.
- Retatrutide is investigational; availability and approval status are discussed during evaluation.
- Weight regain is possible if therapy and lifestyle changes are not maintained.
Frequently Asked Questions
Safety & contraindications
Take the next step
Begin with a confidential consultation
Eligibility and a personalized plan are determined during a private medical consultation. There is no obligation — only clarity.